Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Other Operating Expenses (2020 - 2025)

Alignment Healthcare's Other Operating Expenses history spans 6 years, with the latest figure at $889.5 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 44.67% year-over-year to $889.5 million; the TTM value through Dec 2025 reached $3.5 billion, up 43.4%, while the annual FY2025 figure was $3.5 billion, 43.75% up from the prior year.
  • Other Operating Expenses reached $889.5 million in Q4 2025 per ALHC's latest filing, up from $868.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $889.5 million in Q4 2025 to a low of $251.1 million in Q1 2021.
  • Average Other Operating Expenses over 5 years is $489.3 million, with a median of $404.2 million recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: rose 11.99% in 2022, then skyrocketed 54.34% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $259.6 million in 2021, then increased by 25.59% to $326.0 million in 2022, then rose by 28.12% to $417.7 million in 2023, then surged by 47.19% to $614.8 million in 2024, then skyrocketed by 44.67% to $889.5 million in 2025.
  • Per Business Quant, the three most recent readings for ALHC's Other Operating Expenses are $889.5 million (Q4 2025), $868.0 million (Q3 2025), and $881.7 million (Q2 2025).